search
Search
Board members highlight IFFIm’s value at high-profile events in spring 2025
This spring, IFFIm Board members Rachel Turner and Ingrid van Wees took center stage at major global events, emphasising the power of innovative finance in a pivotal moment for global immunisation. Their discussions underscored how IFFIm’s model…
Reflections on IFFIm: an interview with Rachel Turner
Rachel Turner joined the IFFIm Board of Directors in July 2024, following a long career at the United Kingdom’s Foreign, Commonwealth & Development Office (FCDO). Here, she shares her thoughts on her past work and future possibilities with…
Japanese investors welcome the launch of IFFIm’s debut 'vaccine bonds'
Japanese investors welcomed the launch of the debut offering in the Japanese market of the International Finance Facility for Immunisation Company Tokyo, 4 March 2008 - Japanese investors enthusiastically welcomed the launch of the debut offering…
Japanese retail investors continue to show strong support for vaccine bonds
The most recent offering of vaccine bonds demonstrates Japanese investors' continued support for the International Finance Facility for Immunisation and its humanitarian purpose Tokyo, 24 June 2009 - Vaccine bonds offered to Japanese retail…
Investors get another opportunity to buy vaccine bonds
The International Finance Facility for Immunisation, GAVI Alliance, the World Bank and HSBC Securities (Japan) Limited announce it will begin offering vaccine investment bonds to Japanese retail investors Tokyo, 4 June, 2010 - The International…
Vaccine bonds give Japanese retail investors a special investment opportunity
Multi-tranche bonds raise USD 429 million equivalent, including the largest South African rand denominated uridashi bond to date Tokyo, 5 February 2009 - Vaccine bonds offered to Japanese retail investors in three currencies will raise USD 429…
IFFIm issues sukuk to the Islamic Development Bank
Private transaction raised US$ 50 million for immunisation. London, 9 April 2019 - The International Finance Facility for Immunisation (IFFIm) today completed a private placement sukuk transaction with the Islamic Development Bank Group (IsDB). The…
IFFIm Vaccine Bond issuance named 2019 "Deal of the Year" by mtn-i
London, 6 February 2020 - IFFIm, Skandinaviska Enskilda Banken (SEB) and the Toronto-Dominion Bank have been awarded SRI “Deal of the Year” by news, data and analytics publisher mtn-i for a July 2019 Vaccine Bond issuance that raised funding to…
Islamic Development Bank and IFFIm announce plans to collaborate on private placement
Sukuk aims to build on Gulf Cooperation Council countries' support for Gavi programmes. Abu Dhabi, 11 December 2018 – The International Finance Facility for Immunisation (IFFIm) and the Islamic Development Bank Group (IsDB), a development partner…
Japanese investors continue to show strong interest in vaccine bonds
Uridashi offerings by the International Finance Facility for Immunisation have proved remarkably popular with Japanese retail investors Tokyo, 20 May 2010 - Bonds which raise money to ensure that children in the world's poorest countries can be…
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.